← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (220)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1457)

• Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Antimicrobial Effects of Chemical Compounds Isolated from Traditional Chinese Herbal Medicine (TCHM) Against Drug-Resistant Bacteria: A Review Paper. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Overview on Epidemiology of Tuberculosis. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis control in India: Refocus on nutrition. (2019/01/01) ♡
• Molecular study of mycobacterial strains prevalent in the Czech Republic in 2014. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients (2019-10-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. (2019-07-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Self-verification and Support Via Mobile Phones Drastically Improves Tuberculosis Treatment Success in LMIC Settings (2019-07-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Prospective Patient Registry of Patients Exposed to Bedaquiline (2019-06-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort (2019-06-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace (2019-04-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Xpert MTB/RIF on Patient Outcomes (2019-04-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis (2019-04-10) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Shortening Treatment by Advancing Novel Drugs (2019-03-26) ♡
• Pulmonary tuberculosis screening and quality of life among migrant workers, Northern Thailand. (2018/12/31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study. (2018/12/31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: A retrospective study. (2018/12/31) ♡
• First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon. (2018/12/29) ♡
• Corrigendum: Daru et al., Decentralized, Community-Based Treatment for Drug-Resistant Tuberculosis: Bangladesh Program Experience. (2018/12/27) ♡
• Effect of the duration of antimicrobial exposure on the development of antimicrobial resistance (AMR) for macrolide antibiotics: protocol for a systematic review with a network meta-analysis. (2018/12/23) ♡
• Plasma Levels of Cytokines (IL-10, IFN-γ and TNF-α) in Multidrug Resistant Tuberculosis and Drug Responsive Tuberculosis Patients in Ghana. (2018/12/23) ♡
• Identification of HLA-A2-Restricted Mycobacterial Lipoprotein Z Peptides Recognized by T Cells From Patients With Active Tuberculosis Infection. (2018/12/21) ♡
• Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study. (2018/12/21) ♡
• Representations on adherence to the treatment of Multidrug-Resistant Tuberculosis. (2018/12/20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP). (2018/12/20) ♡
• Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda. (2018/12/19) ♡
• Genome Sequences and Comparative Analysis of Two Extended-Spectrum Extensively-Drug Resistant Mycobacterium tuberculosis Strains. (2018/12/18) ♡
• (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis. (2018/12/17) ♡
• The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU). (2018/12/15) ♡
• MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS IN ADAMAWA STATE, NIGERIA. (2018/12/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges. (2018/12/09) ♡
• Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus. (2018/12/07) ♡
• Drug resistant tuberculosis in Africa: Current status, gaps and opportunities. (2018/12/06) ♡
• Multi-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria. (2018/12/06) ♡
• Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods. (2018/12/06) ♡
• Clostridium difficile in patients attending tuberculosis hospitals in Cape Town, South Africa, 2014-2015. (2018/12/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Closer Look at the Genomic Variation of Geographically Diverse Mycobacterium abscessus Clones That Cause Human Infection and Disease. (2018/12/05) ♡
• Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption. (2018/12/04) ♡
• Spinal Tuberculosis: Current Concepts. (2018/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries. (2018/12/01) ♡
• Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status. (2018/12/01) ♡
• Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa. (2018/12/01) ♡
• Xpert(®) MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis. (2018/12/01) ♡
• Simultaneous diagnosis of tuberculous and non-tuberculous mycobacterial diseases: Time for a better patient management. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis. (2018/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis - Authors' reply. (2018/12/01) ♡
• The Effects of Secondary Pneumonia on the Curative Efficacy of Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. (2018/12/01) ♡
• [Is short-course therapy enough at drug-resistant tuberculosis?]. (2018/12/01) ♡
• Cloning and expression of MPT83 gene from Mycobacterium tuberculosis in E. coli BL21 as vaccine candidate of tuberculosis: A preliminary study. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Niosome-loaded antifungal drugs as an effective nanocarrier system: A mini review. (2018/12/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.